Maxygen Announces Webcast of Presentation at CIBC World Markets First Annual Biotechnology Investor Conference

Apr 30, 2001, 01:00 ET from Maxygen, Inc.

    REDWOOD CITY, Calif., April 30 /PRNewswire/ --
 Maxygen, Inc. (Nasdaq:   MAXY) today announced that its presentation at the CIBC
 World Markets Biotechnology First Annual Biotechnology Investor Conference
 will be webcast live and may be accessed at
 http://cibcwm.com/eq/conference/biotech .
     Russell Howard, chief executive officer of Maxygen, will provide an
 overview of the company's technologies and product pipeline.  The presentation
 will be delivered at 9:15 a.m. (Eastern Daylight Time) on Thursday, May 3,
 from the Millennium Broadway Hotel in New York City.
     Maxygen, Inc. headquartered in Redwood City, California, is focused on
 creating novel products using its integrated proprietary technologies for
 human therapeutics and industrial applications.  Maxygen's technologies bring
 together advances in molecular biology and protein modification to create
 novel biotechnology products.  Maxygen has strategic collaborations with
 leading companies including Lundbeck, Alk-Abello, Pfizer, Chevron, Novozymes,
 DSM, Hercules, Rio Tinto, DuPont and Syngenta as well as U.S.A. government
 funding from DARPA and NIST-ATP.
 
                      MAKE YOUR OPINION COUNT - Click Here
                http://tbutton.prnewswire.com/prn/11690X12782772
 
 

SOURCE Maxygen, Inc.
    REDWOOD CITY, Calif., April 30 /PRNewswire/ --
 Maxygen, Inc. (Nasdaq:   MAXY) today announced that its presentation at the CIBC
 World Markets Biotechnology First Annual Biotechnology Investor Conference
 will be webcast live and may be accessed at
 http://cibcwm.com/eq/conference/biotech .
     Russell Howard, chief executive officer of Maxygen, will provide an
 overview of the company's technologies and product pipeline.  The presentation
 will be delivered at 9:15 a.m. (Eastern Daylight Time) on Thursday, May 3,
 from the Millennium Broadway Hotel in New York City.
     Maxygen, Inc. headquartered in Redwood City, California, is focused on
 creating novel products using its integrated proprietary technologies for
 human therapeutics and industrial applications.  Maxygen's technologies bring
 together advances in molecular biology and protein modification to create
 novel biotechnology products.  Maxygen has strategic collaborations with
 leading companies including Lundbeck, Alk-Abello, Pfizer, Chevron, Novozymes,
 DSM, Hercules, Rio Tinto, DuPont and Syngenta as well as U.S.A. government
 funding from DARPA and NIST-ATP.
 
                      MAKE YOUR OPINION COUNT - Click Here
                http://tbutton.prnewswire.com/prn/11690X12782772
 
 SOURCE  Maxygen, Inc.